Phase 1 UTI Clinical Trials
22 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–20 of 22 trials
Recruiting
Phase 1
Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections
Recurrent UTIsCystitis, Recurrent
University of Texas Southwestern Medical Center104 enrolled2 locationsNCT06907199
Recruiting
Phase 1
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Cognitive ImpairmentSickle Cell DiseaseAttention Deficit Hyperactivity Disorder (ADHD)+1 more
St. Jude Children's Research Hospital72 enrolled1 locationNCT07226219
Recruiting
Phase 1Phase 2
Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism
Autism Spectrum Disorder (ASD)Prospective Study
Dongfang People's Hospital40 enrolled1 locationNCT07243561
Recruiting
Phase 1
Psilocybin for Treatment-Resistant Depression in Autism
Autism Spectrum DisorderTreatment Resistant Depression
Centre for Addiction and Mental Health20 enrolled1 locationNCT06731621
Recruiting
Phase 1Phase 2
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
HealthyGastrointestinal DiseasesAutism Spectrum Disorder
Chang Gung Memorial Hospital60 enrolled1 locationNCT06290258
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Muscular DystrophyLimb Girdle Muscular DystrophyLGMD2I+6 more
AskBio Inc10 enrolled6 locationsNCT05230459
Recruiting
Phase 1Phase 2
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
AutismAutism Spectrum DisorderAutism Spectrum Disorder (ASD)+1 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07304440
Recruiting
Phase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
Johns Hopkins University40 enrolled1 locationNCT05015439
Recruiting
Phase 1
WMT for Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder
The Second Hospital of Nanjing Medical University80 enrolled2 locationsNCT06030752
Recruiting
Phase 1
Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
VEXAS SyndromeVEXASE1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic Syndrome
Washington University School of Medicine15 enrolled1 locationNCT06538181
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism
Autism
The Foundation for Orthopaedics and Regenerative Medicine15 enrolled3 locationsNCT05003960
Recruiting
Phase 1Phase 2
A Chatbot to Support Substance Use Recovery
Opiate Substitution Treatment
Dimagi Inc.55 enrolled1 locationNCT06845878
Recruiting
Phase 1
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
Autism
University of Jordan14 enrolled1 locationNCT06293950
Recruiting
Phase 1
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder
Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.26 enrolled8 locationsNCT06557902
Recruiting
Phase 1
APP-based Emotion Recognition Training Improve ASD Social Function
Autism Spectrum Disorder High-Functioning
University of Electronic Science and Technology of China50 enrolled1 locationNCT06421272
Recruiting
Phase 1
OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.
Pleural CarcinomatosisQuality of LifeChemotherapy Effect+4 more
Odense University Hospital20 enrolled1 locationNCT06421610
Recruiting
Phase 1Phase 2
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
Autism Spectrum DisorderGastrointestinal Symptoms
The University of Texas Health Science Center, Houston70 enrolled1 locationNCT03514784
Completed
Phase 1
A prospective, open label study to evaluate the safety and pharmacokinetics of ML-004-ER under fed and fasted conditions in healthy adult volunteers
Management of patients with autism spectrum disorder
MapLight Therapeutics Inc12 enrolled1 locationACTRN12621000461897
Completed
Phase 1
An interventional study to assess the safety, pharmacokinetic (PK, the measure of how the human body processes a substance) response and tolerability (how well a substance is tolerated by participants) to Zolmitriptan following multiple oral doses in Adult Healthy Volunteers
Autism
Maplight therapeutics48 enrolled1 locationACTRN12620000234910
Withdrawn
Phase 1
A Phase I Study to Determine the Safety of Multiple Oral Doses of Niclosamide in Healthy Volunteers
Therapeutic for Zika virus treatment
Ala Wai Pharma Pty Ltd12 enrolled1 locationACTRN12618001441202